ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 807

A Novel Multi-Network Approach Reveals Tissue-Specific Cellular Modulators of Fibrosis in Systemic Sclerosis, Pulmonary Fibrosis and Pulmonary Arterial Hypertension

Jaclyn N. Taroni1, Casey S. Greene2, Tammara A. Wood3, Romy B. Christmann4, Harrison W. Farber5, Robert A. Lafyatis6, Christopher Denton7, Monique Hinchcliff8, Patricia A. Pioli9, Michael L. Whitfield10 and J. Matthew Mahoney11, 1Department of Molecular & Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, 3Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 4Division of Rheumatology, Boston University Medical School, Boston, MA, 5Pulmonary Center, Boston University Medical Center, Boston, MA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 7Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, 8Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL, 9Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, 10Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 11Department of Neurological Sciences, College of Medicine, University of Vermont, Burlington, VT

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Big data, Bioinformatics, pulmonary fibrosis and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc) is characterized by multi-organ involvement and clinical heterogeneity. “Big data” approaches have yielded powerful tools to infer tissue-specific pathobiology. Large amounts of SSc gene expression data have been generated from different tissues and patient samples with distinct SSc clinical pathology. We performed an integrative meta-analysis of ten different SSc gene expression datasets that identified common disease drivers and tissue-specific distinctions in macrophage (MØ) phenotypes.

Methods: We developed and employed a novel data mining procedure that identified conserved coexpression patterns between ten datasets from four different tissues (skin, lung, esophagus, blood) with multiple clinical manifestations (pulmonary arterial hypertension [PAH], PF, limited and diffuse subtypes). We identified genes and processes that were conserved across all solid tissues and were highly expressed in pulmonary manifestations of SSc. We used these modules to query tissue-specific gene-gene interaction networks and analyzed the resulting lung- and skin-specific networks to infer common and tissue-specific fibrotic and inflammatory pathways.

Results: We identified a common gene signature indicative of an immune fibrotic process (IFP) composed of alternatively activated MØs that contribute to the extracellular matrix (ECM) remodeling processes. This signature was found in PAH and PF in lung, as well as the inflammatory molecular subsets in skin and esophagus. Analysis of the tissue-specific networks revealed a coupling of inflammatory and ECM processes in solid tissues that was absent in PBMC samples. We then rigorously contrasted the lung- and skin-specific gene interaction networks to identify a distinct lung resident MØ signature (LR-MØ) associated with lipid stimulation and alternative activation. Distinct MØ alternative activation transcriptional programs were observed in SSc-PF lung and SSc inflammatory skin.

Conclusion: We find evidence for alternatively activated MØs in multiple SSc tissues. However, there are subtle differences in the MØ transcriptional programs detected in skin and lung uncovered through multi-network systems analyses. In particular, different microenvironments likely provide distinct stimuli to infiltrating MØs that determine the pro-fibrotic character of these cells. This work suggests that the plasticity of this lineage is central to the divergence of fibrotic processes in multiple SSc-affected tissues and is a central component of an immune-fibrotic process driving disease.


Disclosure: J. N. Taroni, None; C. S. Greene, None; T. A. Wood, None; R. B. Christmann, None; H. W. Farber, None; R. A. Lafyatis, None; C. Denton, None; M. Hinchcliff, None; P. A. Pioli, Celdara Medical, LLC., 4; M. L. Whitfield, Gene expression biomarkers in SSc, 9,Celdara Medical LLC, 4; J. M. Mahoney, None.

To cite this abstract in AMA style:

Taroni JN, Greene CS, Wood TA, Christmann RB, Farber HW, Lafyatis RA, Denton C, Hinchcliff M, Pioli PA, Whitfield ML, Mahoney JM. A Novel Multi-Network Approach Reveals Tissue-Specific Cellular Modulators of Fibrosis in Systemic Sclerosis, Pulmonary Fibrosis and Pulmonary Arterial Hypertension [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/a-novel-multi-network-approach-reveals-tissue-specific-cellular-modulators-of-fibrosis-in-systemic-sclerosis-pulmonary-fibrosis-and-pulmonary-arterial-hypertension/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-multi-network-approach-reveals-tissue-specific-cellular-modulators-of-fibrosis-in-systemic-sclerosis-pulmonary-fibrosis-and-pulmonary-arterial-hypertension/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology